| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Arcadia Biosciences, Inc.
$0.57
-0.13 (-18.57%)
Market Cap
1.24 M
EPS
-4.27
P/E Ratio
-
Value Trade
72.33 K
SEC Financials
Q1 2026Dilution Risk
Revenue
1.10 M
Operating CF
-1.10 M
Total Assets
5.32 M
Total Liabilities
2.44 M
Equity
2.88 M
-20.34 %
Week
-8.08 %
1 Month
-46.74 %
3 Month
-67.25 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
3.72 M
Monthly Burn
366.00 K
Runway
7.5 mo
Burn Trend
StableSEC Filing
May 14, 2026
Overview
Volume
691.68 K
52 Week Range
0.50 - 6.71
% held by Insiders
0.16 %
% held by Institutions
17.59 %
Enterprise Value
-2.48 M
Total Shares
2.18 M
Short %
0.15 %
Float Shares
1.97 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in RKDA
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
RKDA Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-RKDA
Aug 13, 2026▼ -18.6%today
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
Arcadia Biosciences reported its financial results for Q2 and the first half of 2026, highlighting a net cash usage of only $319K and a cash balance of $4.2 million. Despite flat sales due to inventory issues, July sales for Zola exceeded $740K, indicating potential growth. The company also raised $4 million through a private placement to support product launches.
Read more →-RKDA
Jun 13, 2026▼ -10.8%on this news· ran to -25% by day 3
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Arcadia Biosciences, Inc. has successfully closed a $4 million private placement under Nasdaq rules. The offering involved the sale of nearly 3.9 million shares of common stock and preferred investment options. The funds will be used for working capital and corporate purposes, although the securities are unregistered and subject to stockholder approval.
Read more →-RKDA
Jun 12, 2026Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Arcadia Biosciences (RKDA) has announced a private placement of approximately $4 million, involving the sale of nearly 3.9 million shares of common stock and associated preferred investment options. The offering is priced at $1.03 per share and is expected to close on June 12, 2026, pending customary conditions. The funds will be used for working capital and general corporate purposes.
Read more →-RKDA
May 14, 2026Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights -- Zola volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia's history -- DALLAS, Texas (
Arcadia Biosciences (RKDA) reported its first-quarter 2026 financial results, highlighting an 18% increase in Zola coconut water volumes year-over-year. However, total revenues dropped by 8%, resulting in a significant net loss of $4.4 million compared to a gain in the same period last year. The company's selling, general, and administrative expenses reached a historic low, and future product launches are anticipated. Despite these positive aspects, the company indicated a need for additional funding to support ongoing operations.
Read more →-RKDA
Mar 27, 2026Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights
Arcadia Biosciences, Inc. reported its financial results for Q4 and full year 2025, highlighting a 17% increase in Zola revenues. However, total revenues decreased by 4% year-over-year, influenced by the absence of GLA oil sales. The company also announced the termination of its proposed business combination with Roosevelt Resources, while reducing SG&A expenses significantly.
Read more →-RKDA
Jan 12, 2026▼ -11.6%on this news
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds DALLAS, Texas (
Arcadia Biosciences (RKDA) has announced the exercise of preferred investment options, generating approximately $2.1 million in gross proceeds. The options allow investment in 808,595 shares at a reduced price, reflecting a strategic financial move. Furthermore, the company plans to issue new preferred investment options for additional funding. Proceeds from the exercise will be used for working capital and general corporate purposes. The closing of this offering is anticipated to occur on or about January 12, 2026, pending customary conditions.
Read more →-RKDA
Dec 29, 2025▼ -15.4%on this news· ran to -30% by day 1
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
Arcadia Biosciences has received a termination notice from Roosevelt Resources regarding their proposed business combination. CEO T.J. Schaefer stated that the company will explore strategic alternatives to enhance shareholder value. Despite the termination, Arcadia has made operational improvements and continues to hold valuable assets, including shares in Above Food Ingredients Inc.
Read more →-RKDA
Dec 29, 2025▼ -15.4%on this news· ran to -30% by day 1shared move
beliefs concerning the availability of adequate funding to support the company's future operations from available cash resources, revenues from future sales of products, proceeds from sales of assets including shares of
Arcadia Biosciences (RKDA) announced on December 24, 2025, that it received a termination notice from Roosevelt Resources regarding their proposed business combination. As a result, Arcadia will reassess its strategic options to increase shareholder value. Despite having valuable assets and a streamlined operation, the company faces uncertainty and may require additional funding to sustain its operations. Failure to secure funding could lead to significant operational risks.
Read more →-RKDA
Nov 7, 2025▼ -5.4%on this news
Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights -- Zola year-to-date revenues increase 26% year over year -- -- Arcadia gross profit margins exceed 30% for 11 th straight
Arcadia Biosciences (RKDA) reported its financial results for Q3 2025, highlighting a year-to-date revenue increase of 26% for Zola coconut water. Despite an overall revenue decrease in Q3 due to absent sales of GLA oil, the company noted significant improvements in gross profit margins and cash management. The company is also navigating the complexities of a pending business combination with Roosevelt Resources amidst a federal government shutdown. Net income attributable to common stockholders showed notable improvement compared to the previous year.
Read more →-RKDA
Aug 14, 2025Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights -- Arcadia revenues increase 11% year over year driven by 24% growth in Zola -- -- Arcadia receives 2.7 mi
Arcadia Biosciences (RKDA) reported an 11% year-over-year increase in revenues for the second quarter of 2025, driven primarily by a 24% growth in Zola coconut water sales. The company also eliminated $1 million in liabilities, contributing to an improved financial outlook. However, a significant net loss of $4.5 million was reported, largely due to a credit loss related to a note receivable from Above Food. The ongoing business combination with Roosevelt Resources is proceeding, emphasizing the company’s commitment to strategic transitions.
Read more →-RKDA
May 8, 2025Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights -- Revenues increase 22% year over year driven by 90% growth in Zola -- -- Arcadia sells patents for $750K and eliminates
Arcadia Biosciences (RKDA) reported a strong performance in the first quarter of 2025, with revenues rising 22% driven primarily by significant growth in Zola coconut water sales. The company also achieved a notable net income of $2.6 million, highlighting an impressive turnaround from a loss in the previous year. Additionally, Arcadia made strategic moves by selling patents for $750,000 and eliminating $1 million in liabilities, all while preparing for a business combination with Roosevelt Resources. The management expressed confidence in maintaining growth momentum as they progress with operational streamlining.
Read more →-RKDA
Mar 20, 2025Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights -- Year-over-year revenues grew 56% in Q4 and 13% for full year -- -- Zola year-over-year revenues increase
Arcadia Biosciences (RKDA) reported a strong financial performance with a 56% revenue increase in Q4 2024 and 13% for the full year, driven by significant growth in its Zola coconut water brand. The company also announced a business combination with Roosevelt Resources, which aims to bolster its market presence. Despite this progress, Arcadia faced a rising net loss attributable to common stockholders in Q4, attributed mainly to changes in stock liabilities. However, cost controls were highlighted as a positive aspect, leading to the lowest operational cash use since going public.
Read more →-RKDA
Dec 11, 2024Arcadia Biosciences & Roosevelt Resources Business Combination December 2024 Filed by Arcadia Biosciences, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Sec
Arcadia Biosciences has filed for a business combination with Roosevelt Resources slated for December 2024. The filing is made under the relevant securities laws, and outlines potential benefits including enhanced operational capabilities and future growth opportunities for the combined entity. However, there are risks involved, such as the need for stockholder approval and uncertainties regarding post-transaction integration. The forward-looking statements included in the filing highlight various risks that could lead to different outcomes than expected.
Read more →-RKDA
Dec 6, 2024Arcadia Biosciences Contact: Roosevelt Resources Contact: Sue Wandell Jerrel Branson ir@arcadiabio.com jerrel@rooseveltresources.com ARCADIA BIOSCIENCES (RKDA) ENTERS INTO BUSINESS COMBINATION AGREEMENT WITH ROOSEVELT RE
Arcadia Biosciences (RKDA) has entered into a definitive securities exchange agreement with Roosevelt Resources, marking a significant all-stock transaction. The agreement, which expects to close in the first quarter of 2025, will result in Arcadia issuing shares to Roosevelt’s partners. This move comes after Arcadia's strategic review aimed at maximizing shareholder value and streamlining operations. Roosevelt Resources brings a large carbon capture and oil project with considerable development potential, positioning the combined entity for future growth.
Read more →-RKDA
Nov 12, 2024Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights -- Total revenues increased 18% compared to Q3 2023 – -- Zola coconut water revenues grew 55% year over year
Arcadia Biosciences (RKDA) reported strong financial results for Q3 2024, with total revenues rising 18% year over year, largely driven by the success of its Zola coconut water product, which experienced a 55% revenue growth. Retail distribution for Zola has also increased significantly, up 68% compared to last year. The company is experiencing an overall positive trend in revenue and market share, despite facing increased operating expenses and continued net losses. Arcadia's management expressed optimism regarding their strategic achievements and long-term business transformation.
Read more →-RKDA
Aug 13, 2024Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights -- Company closes $4M transaction with Corteva Agriscience -- -- Above Food Corp acquires GoodWheat TM bra
Arcadia Biosciences (RKDA) reported its financial results for the second quarter and first half of 2024, highlighting significant operational improvements. The company secured $4 million through the sale of its resistant starch wheat trait to Corteva Agriscience and sold its GoodWheat brand to Above Food Corp for a similar amount over three years. Zola coconut water saw a remarkable 42% increase in sales year-over-year, indicating strong market demand. However, overall revenue for the first half decreased modestly, and the company is still adjusting its organizational structure.
Read more →-RKDA
May 14, 2024▲ +31.5%on this news· ran to +50% by day 3
ARCADIA BIOSCIENCES, INC. UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION On
Arcadia Biosciences, Inc. has completed the sale of its GoodWheat business to Above Food Corp. for a total consideration of $4,000,000, which includes a cash payment and a promissory note. The company has released unaudited pro forma consolidated financial statements reflecting this transaction. While this sale provides immediate cash flow, it raises concerns about the company's ongoing financial performance and future operational focus. The pro forma information is illustrative and may not indicate the company’s future conditions accurately.
Read more →-RKDA
May 9, 2024Arcadia Biosciences (RKDA) Announces First Quarter 2024 Financial Results and Business Highlights – Revenues increase sequentially and year-over-year – – Loss from continuing operations is at lowest
Arcadia Biosciences (RKDA) reported its first quarter 2024 results, showing a slight increase in revenues compared to the previous year, attributed to its GoodWheat and Zola product lines. The loss from continuing operations has decreased to the lowest level in six years, while operating expenses have seen a notable decline. The company continues to focus on expanding the distribution of its products, with GoodWheat and Zola set to be key growth drivers. Improvements were also noted in net loss attributable to common stockholders, significantly enhanced from the prior year's quarter.
Read more →-RKDA
Mar 28, 2024Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights -- Second continuous year of gross profit growth -- -- Total SG&A expenses declined to the lowest levels si
Arcadia Biosciences (RKDA) reported its fourth-quarter and full-year financial results for 2023, highlighting a second consecutive year of gross profit growth. The company's focus on its GoodWheat product line has led to increased revenues and the introduction of new product categories, including pancake mixes and mac & cheese. Despite a reduction in SG&A expenses and operational improvements, the overall revenues for the year decreased compared to 2022. The company also experienced significant net losses, though these improved marginally from the previous year.
Read more →-RKDA
Nov 9, 2023Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023 Financial Results and Business Highlights -- Increased revenue from continuing operations 20% quarter over quarter -- -- Lowest SG&A expenses since 2019 -- -
Arcadia Biosciences (RKDA) reported strong third quarter financial results with a 20% increase in revenue from continuing operations compared to the previous quarter. The company's SG&A expenses reached their lowest level since 2019, contributing to a more streamlined cost structure. The introduction of GoodWheat Mac & Cheese is set to expand their product categories, capitalizing on the growing demand for healthier options. However, year-over-year revenue remains down by 38%, and the company continues to face significant net losses.
Read more →-RKDA
Aug 10, 2023Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights • GoodWheat TM expands into breakfast category with the launch of better-for-you pancake and waffle
Arcadia Biosciences (RKDA) recently announced its second-quarter and first-half 2023 financial results, highlighting a decrease in total revenues, which fell by $2.5 million and $4.2 million respectively. The company's latest initiatives, including the launch of GoodWheat pancake and waffle mixes, aim to capitalize on growth in the food sector while reducing operating costs by winding down its Body Care brands. Despite the decrease in revenues, Arcadia has reported an improvement in net income for the second quarter, partially due to significant strategic shifts and a newly engaged review process for exploring potential transactions. The financial performance and strategic direction reflect a focus on maximizing shareholder value amidst operational challenges.
Read more →-RKDA
Jul 20, 2023Arcadia Biosciences (RKDA) Announces Strategic Review – Company will explore a range of potential strategies to drive shareholder value – DAVIS, Calif. (
Arcadia Biosciences (RKDA) has announced the commencement of a strategic review aimed at maximizing long-term shareholder value. The company will evaluate various strategic options, including potential acquisitions and mergers, with Lake Street Capital Markets serving as the financial advisor. Alongside this effort, Arcadia plans to streamline its operations by exiting certain body care brands, potentially saving millions in operating expenses. The company currently holds around $18.8 million in cash and is fostering growth through innovative product launches.
Read more →-RKDA
May 11, 2023Arcadia Biosciences (RKDA) Announces First Quarter 2023 Financial Results from Operations and Business Highlights – Significant improvement in gross profit dollars compared to last year – – GoodWheat
Arcadia Biosciences (RKDA) announced its financial results for Q1 2023, revealing a significant improvement in gross profit compared to the previous year. Despite a 53% decline in total revenues, the company's focus on high-quality revenue streams has resulted in better gross profit dollars due to reduced costs in various segments. GoodWheat pasta's recognition as the Best New Product reflects the brand's growing presence in the market. CEO Stan Jacot outlined plans for continued growth and expansion under Project Greenfield, with expectations for further innovations and category expansions.
Read more →-RKDA
Mar 30, 2023Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights -- Total revenues increased 47% compared to prior year -- -- Total operating expenses declined 32% year-ove
Arcadia Biosciences (RKDA) announced its financial results for Q4 and full year 2022, reporting a 47% increase in total revenues compared to the previous year. The company also saw a significant decline in operating expenses by 32%, showcasing improved financial performance. Key highlights from the year include the successful launch of its GoodWheatTM pasta, which has expanded to over 1,200 retail locations. CEO Stan Jacot outlined a long-term strategy through Project Greenfield aimed at increasing shareholder value and profitability despite a reported net loss for the year.
Read more →-RKDA
Nov 30, 2022Arcadia Biosciences (RKDA) Announces CFO Transition -- Pam Haley to be replaced by Thomas J. Schaefer effective
Arcadia Biosciences (RKDA) Announces CFO Transition -- Pam Haley to be replaced by Thomas J. Schaefer effective January 3, 2023 -- DAVIS, Calif. (November 30, 2022) Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness
Read more →-RKDA
Nov 10, 2022▲ +5.3%on this news
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2022 Financial Results and Business Highlights -- GoodWheat TM Pasta distribution doubles from Q2 -- -- Gross margins improve to 28% -- -- Streamlined operations
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2022 Financial Results and Business Highlights -- GoodWheatTM Pasta distribution doubles from Q2 -- -- Gross margins improve to 28% -- -- Streamlined operations focus on higher-margin brands -- DAVIS, Calif. (November
Read more →-RKDA
Aug 12, 2022▲ +12.6%on this news
Execution Version
STRICTLY CONFIDENTIAL Arcadia Biosciences, Inc. 202 Cousteau Place, Suite 105 Davis, California 9561 Attn: Stanley E. Jacot, Jr., President and Chief Executive Officer This letter agreement (this Agreement ) constitutes the agreement between Arcadia Biosciences, Inc. (the Co
Read more →-RKDA
Aug 11, 2022Arcadia Biosciences (RKDA) Announces Strong Second-Quarter and First-Half 2022 Financial Results and Business Highlights – Revenue increased 175% from Q2 2021 – – GoodWheat TM pasta successfully laun
Arcadia Biosciences (RKDA) Announces Strong Second-Quarter and First-Half 2022 Financial Results and Business Highlights Revenue increased 175% from Q2 2021 GoodWheatTM pasta successfully launched in retail and online $2M milestone achievement recognized for HB4 soybean approv
Read more →-RKDA
May 12, 2022Arcadia Biosciences (RKDA) Announces First Quarter 2022 Financial Results – Sales increased 48% from Q4 2021 – – First retail orders of Good Wheat TM pasta shipped – -- HB4 soybeans approved i
Arcadia Biosciences (RKDA) Announces First Quarter 2022 Sales increased 48% from Q4 2021 First retail orders of Good WheatTM pasta shipped -- HB4 soybeans approved in China, $2M milestone anticipated -- DAVIS, Calif. (May 12, 2022) Arcadia Biosciences, Inc. (Nasdaq: RKDA), a
Read more →-RKDA
Mar 30, 2022Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights – Strong balance sheet entering 2022 – – Expanded consumer product offerings in on-tre
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights Strong balance sheet entering 2022 Expanded consumer product offerings in on-trend categories Experienced CPG talent added throughout organization DAVIS, Calif. (M
Read more →-RKDA
Feb 2, 2022Arcadia Biosciences (RKDA) Names Stan Jacot as CEO Transformational change leader and CPG veteran brings 30 years of experience building high-functioning teams, driving organizational growth DAVIS, Calif. (
Arcadia Biosciences (RKDA) Names Stan Jacot as CEO Transformational change leader and CPG veteran brings 30 years of experience building high-functioning teams, driving organizational growth DAVIS, Calif. (February 2, 2022) Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer a
Read more →-RKDA
Dec 20, 2021Arcadia Biosciences (RKDA) Appoints Kevin Comcowich to Interim CEO DAVIS, Calif. (
Arcadia Biosciences (RKDA) Appoints Kevin Comcowich to Interim CEO DAVIS, Calif. (December 20, 2021) Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced it has appointed Kevin Comcowich, current Cha
Read more →-RKDA
Nov 15, 2021Arcadia Biosciences (RKDA) Announces Strong Third-Quarter Financial Results and Business Highlights Revenues for quarter up six-fold, year-to-date up four-fold DAVIS, Calif. (
Arcadia Biosciences (RKDA) Announces Strong Third-Quarter Financial Results and Business Highlights Revenues for quarter up six-fold, year-to-date up four-fold DAVIS, Calif. (November 15, 2021) Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative, pla
Read more →-RKDA
Sep 7, 2021Arcadia Biosciences Announces Leadership Transition -- Company seeks new CEO as it further expands into consumer packaged goods; Matt Plavan to step down when successor is named
Arcadia Biosciences Announces Leadership Transition -- Company seeks new CEO as it further expands into consumer packaged goods; Matt Plavan to step down when successor is named -- DAVIS, Calif., September 7, 2021 - Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marke
Read more →-RKDA
Aug 16, 2021Arcadia Biosciences Announces Strong Second-Quarter and First-Half 2021 Financial Results and Business Highlights Revenues for quarter up five-fold, year-to-date up four-fold DAVIS, Calif. (
Arcadia Biosciences Announces Strong Second-Quarter and First-Half 2021 Financial Results and Business Highlights Revenues for quarter up five-fold, year-to-date up four-fold DAVIS, Calif. (August 16, 2021) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of
Read more →-RKDA
May 17, 2021Arcadia Biosciences (RKDA) Announces First-Quarter 2021 Financial Results and Business Highlights -- Revenues up for the quarter over 160%, liquidity strengthened -- -- Acquires Lief assets, a premium portfolio of CBD an
Arcadia Biosciences (RKDA) Announces First-Quarter 2021 Financial Results and Business Highlights -- Revenues up for the quarter over 160%, liquidity strengthened -- -- Acquires Lief assets, a premium portfolio of CBD and wellness brands, bringing immediate top-line revenue, ma
Read more →-RKDA
Mar 30, 2021Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights - Record revenues, up six-fold over prior year - - Strong balance sheet entering 2021 - - Expanded product
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights - Record revenues, up six-fold over prior year - - Strong balance sheet entering 2021 - - Expanded product offerings - DAVIS, Calif. (March 30, 2021) - Arcadia Bio
Read more →-RKDA
Feb 24, 2021Arcadia Biosciences Welcomes Debbie Carosella to Board Of Directors -- Prominent leader in consumer food industry will help guide commercialization strategy for innovative health and nutrition ingredients -- DAVIS, Calif
Arcadia Biosciences Welcomes Debbie Carosella to Board Of Directors -- Prominent leader in consumer food industry will help guide commercialization strategy for innovative health and nutrition ingredients -- DAVIS, Calif. (February 24, 2021) - Arcadia Biosciences, Inc. (Nasdaq:
Read more →-RKDA
Nov 18, 2020Arcadia Biosciences, Inc. Unaudited Pro Forma Condensed Consolidated Financial Information as of
Arcadia Biosciences, Inc. Unaudited Pro Forma Condensed Consolidated Financial Information as of September 30, 2020, and December 31, 2019 The following unaudited pro forma condensed consolidated financial information ("pro forma financial information") is disclosed to show the
Read more →-RKDA
Nov 12, 2020Arcadia Biosciences Announces Third-Quarter
Arcadia Biosciences Announces Third-Quarter September 30, 2020 Financial Results and Business Highlights - Executes strategic transaction with Bioceres Crop Solutions (BIOX), bringing $8 million in up-front and contingent cash, 1.875 million BIOX shares and trait royalties of up
Read more →-RKDA
Aug 13, 2020Arcadia Biosciences Announces Second-Quarter and First-Half 2020 Financial Results and Business Highlights Revenues up 38% for the quarter and 63% year to date Multiple GoodWheat TM distribution agreements position compa
Arcadia Biosciences Announces Second-Quarter and First-Half 2020 Financial Results and Business Highlights DAVIS, Calif. (August 13, 2020) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and
Read more →-RKDA
May 13, 2020Arcadia Biosciences Announces First-Quarter 2020 Financial Results and Business Highlights -- First Quarter Revenue Up Year over Year -- -- Provides Update on COVID-19 Impact and Reiterates 2020 Revenue Guidance of $10 M
Arcadia Biosciences Announces First-Quarter 2020 Financial Results and Business Highlights -- First Quarter Revenue Up Year over Year -- -- Provides Update on COVID-19 Impact and Reiterates 2020 Revenue Guidance of $10 Million -- -- Management to Host Conference Call Today at
Read more →-RKDA
Mar 25, 2020Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights Company introduced high-value hemp innovations while continuing to commercialize innovative food ingredients and a
Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights Company introduced high-value hemp innovations while continuing to commercialize innovative food ingredients and agricultural productivity traits DAVIS, Calif. (March 25, 2
Read more →-RKDA
Nov 6, 2019Lisa Weser, Trailblaze lisa@trailblaze.co +1 (314) 625-4633 Arcadia Biosciences Announces Third-Quarter 2019 Financial Results and Business Highlights -- Company announces plans for h
Media Contact: Lisa Weser, Trailblaze lisa@trailblaze.co +1 (314) 625-4633 Arcadia Biosciences Announces Third-Quarter 2019 Financial Results and Business Highlights -- Company announces plans for hemp seed sales, highlights first GoodWheatTM sales commitments and USDA app
Read more →-RKDA
Aug 14, 2019Lisa Weser, Trailblaze lisa@trailblaze.co +1 (314) 625-4633 Arcadia Biosciences Announces Second-Quarter and First-Half 2019 Financial Results and Business Highlights Company launches
Media Contact:Lisa Weser, Trailblaze Arcadia Biosciences Announces Second-Quarter and First-Half 2019 Financial Results and Business Highlights Company launches ArchipelagoTM Ventures, a strategic joint venture for superior hemp production and extraction in Hawaii DAVIS, Calif
Read more →-RKDA
May 8, 2019Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Announces First-Quarter 2019 Financial Results and Business Highlights Company launches new business unit, A
Arcadia Biosciences Announces First-Quarter 2019 Financial Results and Business Highlights Company launches new business unit, Arcadia Specialty GenomicsTM, to apply its advanced plant breeding and gene editing expertise to cannabis DAVIS, Calif. (May 8, 2019) - Arcadia Bioscie
Read more →-RKDA
Mar 27, 2019Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights -- Company delivers re
Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights -- Company delivers regulatory, scientific and commercial progress in four crops, and launches new strategy in cannabis -- DAVIS, Calif. (March 27, 2019) - Arcadia Bioscie
Read more →-RKDA
Feb 28, 2019Arcadia Biosciences, a Leader in Advanced Agricultural Breeding and Gene Optimization, Announces New Business Unit Dedicated to Cannabis Arcadia Specialty Genomics to bring standardization and optimization to America's c
Arcadia Biosciences, a Leader in Advanced Agricultural Breeding and Gene Optimization, Announces New Business Unit Dedicated to Cannabis Arcadia Specialty Genomics to bring standardization and optimization to America's cannabis crop with a focus on improved plant quality, res
Read more →-RKDA
Nov 7, 2018Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Announces Third-Quarter and Nine-Month 2018 Financial Results and Business Highlights DAVIS, Calif. (
Media Contact: Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Announces Third-Quarter and Nine-Month 2018 Financial Results and Business Highlights DAVIS, Calif. (November 7, 2018) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural food in
Read more →-RKDA
Aug 8, 2018Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES SECOND QUARTER AND FIRST-HALF 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES SECOND QUARTER AND FIRST-HALF 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (August 8, 2018) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient company, today released its financial and business results for t
Read more →-RKDA
May 15, 2018Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Albert D. Bolles, Ph.D. Joins Arcadia Biosciences Board Of Directors -- Prominent consumer food industry executive will help gui
Albert D. Bolles, Ph.D. Joins Arcadia Biosciences Board Of Directors -- Prominent consumer food industry executive will help guide commercialization strategy for innovative health and nutrition ingredients -- DAVIS, Calif. (May 15, 2018) - Arcadia Biosciences, Inc. (Nasdaq: RKD
Read more →-RKDA
May 9, 2018Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES FIRST-QUARTER 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS -- A strong start to 2018 in product
ARCADIA BIOSCIENCES ANNOUNCES FIRST-QUARTER 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS -- A strong start to 2018 in product development and commercialization plans for consumer-driven health and nutrition ingredient products, fifth consecutive reduction in year-over-year qu
Read more →-RKDA
Mar 20, 2018Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS -- Revenues Up, Losses
ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS -- Revenues Up, Losses Down, Commercialization Plans Underway for Consumer-Driven Health and Nutrition Ingredient Traits -- DAVIS, Calif. (March 20, 2018) - Arcadia Biosc
Read more →-RKDA
Mar 19, 2018Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Announces $10 Million Private Placement DAVIS, Calif. (
Contact: Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Announces $10 Million Private Placement DAVIS, Calif. (March 19, 2018) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company, announced today that it has entered into
Read more →-RKDA
Nov 9, 2017Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES THIRD-QUARTER AND NINE MONTH 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES THIRD-QUARTER AND NINE MONTH 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (November 9, 2017) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates value for farmers while benefitting the environ
Read more →-RKDA
Aug 10, 2017Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES SECOND-QUARTER AND FIRST-HALF 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS -- Revenues Up, Expen
ARCADIA BIOSCIENCES ANNOUNCES SECOND-QUARTER AND FIRST-HALF 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS -- Revenues Up, Expenses and Net Loss Down -- DAVIS, Calif. (August 10, 2017) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates
Read more →-RKDA
May 10, 2017Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES FIRST-QUARTER 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES FIRST-QUARTER 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (May 10, 2017) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates value for farmers while benefitting the environment and enhancing
Read more →-RKDA
Mar 8, 2017Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2016 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2016 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (March 8, 2017) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates value for farmers while benefitting the environmen
Read more →-RKDA
Nov 10, 2016Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES THIRD-QUARTER 2016 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES THIRD-QUARTER 2016 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (November 10, 2016) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates value for farmers while benefitting the environment and enhan
Read more →-RKDA
Nov 2, 2016Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Adds Kevin Comcowich to Its Board Of Directors -- Experienced Business and Finance Leader Enhances Board Dep
Arcadia Biosciences Adds Kevin Comcowich to Its Board Of Directors -- Experienced Business and Finance Leader Enhances Board Depth -- DAVIS, Calif. (November 2, 2016) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates value for farmers w
Read more →-RKDA
Sep 8, 2016Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Names New Chief Financial Officer -- Experienced Executive Further Strengthens Seasoned Management Team -- D
Arcadia Biosciences Names New Chief Financial Officer -- Experienced Executive Further Strengthens Seasoned Management Team -- DAVIS, Calif. (September 8, 2016) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates value for farmers while b
Read more →-RKDA
Aug 9, 2016Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES SECOND-QUARTER AND FIRST-HALF 2016 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES SECOND-QUARTER AND FIRST-HALF 2016 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (August 9, 2016) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates value for farmers while benefitting the environm
Read more →-RKDA
Jul 21, 2016S t anl e y Higgins S e nior Di rec tor L isting Qu a li f i ca tions The N a sd a q S to c k M ar k e t LL C +1 301 978 8041 By El ec tronic D e li ve ry to st eve .brand w e in@ar c a d iabio. c om
Senior Director Listing Qualifications The Nasdaq Stock Market LLC By Electronic Delivery to steve.brandwein@arcadiabio.com Interim CFO / VP Finance and Administration Arcadia Biosciences, Inc. As you are aware, on July 9, 2016, two of the Company's independent directors, Mr
Read more →-RKDA
Jul 14, 2016Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Announces Changes in Board of Directors DAVIS, Calif. (
Arcadia Biosciences Announces Changes in Board of Directors DAVIS, Calif. (July 14, 2016) Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company, announced the resignation of two members of its board of directors, effective July 9, 2016. Matthew A. Ankrum
Read more →-RKDA
May 10, 2016Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES FIRST-QUARTER 2016 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES FIRST-QUARTER 2016 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (May 10, 2016) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company that creates value for farmers while benefitting the environment and enhancing
Read more →-RKDA
Mar 8, 2016Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2015 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2015 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (March 8, 2016) - Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company focused on generating higher yields and improving product quali
Read more →-RKDA
Feb 11, 2016Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES DEPARTURE OF CEO FOR MEDICAL REASONS AND CHANGES IN BOARD OF DIRECTORS DAVIS, Calif. (
Media Contact: Jeff Bergau jeff.bergau@arcadiabio.com ARCADIA BIOSCIENCES ANNOUNCES DEPARTURE OF CEO FOR MEDICAL REASONS AND CHANGES IN BOARD OF DIRECTORS DAVIS, Calif. (February 11, 2016) Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company, today ann
Read more →-RKDA
Jan 13, 2016Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences CEO to Take Short-Term Medical Leave DAVIS, Calif . (
Contact: Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences CEO to Take Short-Term Medical Leave DAVIS, Calif. (January 13, 2016) Arcadia Biosciences, Inc. (Nasdaq: RKDA) announced today that President and Chief Executive Officer Eric Rey will be t
Read more →-RKDA
Dec 30, 2015Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Refinances and Consolidates Debt with Silicon Valley Bank, Reducing Cost of Capital DAVIS, Calif. (
Contact: Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Refinances and Consolidates Debt with Silicon Valley Bank, Reducing Cost of Capital DAVIS, Calif. (December 30, 2015) Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology c
Read more →-RKDA
Nov 5, 2015Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES THIRD QUARTER 2015 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (November 5, 2015) - Arcadia Biosciences, Inc. (NASDAQ: RKDA), an agricultural technology company with 50 pipeline products focused on generating higher yields and improving
Read more →-RKDA
Oct 5, 2015Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 Arcadia Biosciences Announces CFO Change; Names Steve Brandwein as Interim CFO DAVIS, Calif. (
Arcadia Biosciences Announces CFO Change; Names Steve Brandwein as Interim CFO DAVIS, Calif. (October 5, 2015) Arcadia Biosciences, Inc. (NASDAQ: RKDA), an agricultural technology company, today announced that chief financial officer Thomas O Neil will be leaving the company t
Read more →-RKDA
Aug 10, 2015Jeff Bergau jeff.bergau@arcadiabio.com +1-312-217-0419 ARCADIA BIOSCIENCES ANNOUNCES SECOND-QUARTER AND FIRST-HALF 2015 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS DAVIS, Calif. (
ARCADIA BIOSCIENCES ANNOUNCES SECOND-QUARTER AND FIRST-HALF 2015 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS Calif. (August 10, 2015) Arcadia Biosciences, Inc. (NASDAQ: RKDA), an agricultural technology company with more than 50 pipeline products focused on generating higher yiel
Read more →Competitive Position
How RKDA ranks across every disease it competes inCompetitive Position is a premium feature
See how RKDA ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial